These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2031996)

  • 1. Distribution kinetics of netilmicin in human blister fluid: effect of renal impairment.
    Lanao JM; López A; Domínguez-Gil A; Martin J; Gómez JR; Tabernero JM
    Biopharm Drug Dispos; 1991 Mar; 12(2):149-62. PubMed ID: 2031996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amikacin concentrations in serum and blister fluid in healthy volunteers and in patients with renal impairment.
    Lanao JM; Navarro AS; Dominguez-Gil A; Tabernero JM; Rodriguez IC; Gonzalez Lopez A
    J Antimicrob Chemother; 1983 Nov; 12(5):481-8. PubMed ID: 6671925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of renal impairment on distribution of ofloxacin.
    Sanchez Navarro A; Martinez Lanao J; Sanchez Recio MM; Domínguez-Gil Hurlé A; Tabernero Romo JM; Gomez Sanchez JC; Terreiro Delgado MM
    Antimicrob Agents Chemother; 1990 Mar; 34(3):455-9. PubMed ID: 2334157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interface-area-to-volume ratio of interstitial fluid in humans determined by pharmacokinetic analysis of netilmicin in small and large skin blisters.
    Blaser J; Rieder HL; Lüthy R
    Antimicrob Agents Chemother; 1991 May; 35(5):837-9. PubMed ID: 1854165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of netilmicin in renal insufficiency and hemodialysis.
    Herrero A; Rius Alarcó F; García Díez JM; Mahiques E; Domingo JV
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):84-7. PubMed ID: 3045024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of netilmicin in renal insufficiency and haemodialysis.
    Pechere JC; Dugal R; Pechere MM
    Clin Pharmacokinet; 1978; 3(5):395-406. PubMed ID: 699461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A
    Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of netilmicin in short-term prophylactic treatment.
    Jauregizar N; Wald JA; Astobieta A; Rodriguez Sasiain JM; Lukas JC; Calvo R
    Br J Clin Pharmacol; 2003 Jun; 55(6):552-9. PubMed ID: 12814449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of netilmicin in patients with renal impairment and in patients on dialysis.
    Luft FC; Brannon DR; Stropes LL; Costello RJ; Sloan RS; Maxwell DR
    Antimicrob Agents Chemother; 1978 Sep; 14(3):403-7. PubMed ID: 708018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefetamet in plasma and skin blister fluid.
    Zimmerli W; Sansano S; Wittke B
    Antimicrob Agents Chemother; 1996 Jan; 40(1):102-4. PubMed ID: 8787888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transfer of fosfomycin into human burn blister fluid and its pharmacokinetic analysis].
    Koh B; Izawa Y; Sugiyama H; Aoyama H; Komiya I
    Jpn J Antibiot; 1986 Nov; 39(11):2863-8. PubMed ID: 3820568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfonamide and trimethoprim concentrations in human serum and skin blister fluid.
    Bruun JN; Ostby N; Bredesen JE; Kierulf P; Lunde PK
    Antimicrob Agents Chemother; 1981 Jan; 19(1):82-5. PubMed ID: 7247364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does cantharides blister fluid provide access to the peripheral compartment?
    Schäfer-Korting M; Korting HC; Hiemstra S; Mutschler E
    Eur J Clin Pharmacol; 1982 Oct; 23(4):327-30. PubMed ID: 7173302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human plasma and skin blister fluid levels of griseofulvin following a single oral dose.
    Schäfer-Korting M; Korting HC; Mutschler E
    Eur J Clin Pharmacol; 1985; 29(1):109-13. PubMed ID: 4054199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ciprofloxacin in healthy volunteers and patients with impaired kidney function.
    Webb DB; Roberts DE; Williams JD; Asscher AW
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():83-7. PubMed ID: 3804907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transfer of cefmenoxime to burn blister fluids].
    Nishizaki A; Aoyama H; Koh T; Izawa Y
    Jpn J Antibiot; 1984 Mar; 37(3):295-302. PubMed ID: 6330396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Netilmicin kinetics in urology.
    Astobieta A; Calvo R; Aguirre C; Rodríguez-Sasiain JM
    Int J Clin Pharmacol Ther Toxicol; 1993 Nov; 31(11):557-60. PubMed ID: 8294169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of a one-compartment model for determining netilmicin pharmacokinetic parameters and dosage recommendations.
    Rotschafer JC; Crossley KB; Zaske DE; Russillo NJ; Strate RG; Tofte RW; Solem LD
    Ther Drug Monit; 1983; 5(3):263-7. PubMed ID: 6636253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ibuprofen enantiomers in plasma and suction blister fluid in healthy volunteers.
    Walker JS; Knihinicki RD; Seideman P; Day RO
    J Pharm Sci; 1993 Aug; 82(8):787-90. PubMed ID: 8377114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicompartment pharmacokinetics of netilmicin.
    Wenk M; Spring P; Vozeh S; Follath F
    Eur J Clin Pharmacol; 1979 Nov; 16(5):331-4. PubMed ID: 520400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.